This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Digging into the opioid reversal market and potential use of OPNT003

Ticker(s): OPNT, INVVY

Who's the expert?

Institution: Ohio Department of Public Safety

  • State Medical Director for the Ohio Department of Public Safety, Division of EMS, board-certified emergency physician at Cleveland Clinic Akron General Medical Center and an associate professor of emergency medicine at Northeast Ohio Medical University
  • Co-principal investigator for the National Association of State EMS Officials (NASEMSO) National Model EMS Clinical Guidelines project.
  • Makes recommendations on behalf of the Ohio Department of Public Safety to comptrollers as to how much naloxone should be purchased in bulk and creates the naloxone modules, trainings and presentations
  • Nationally recognized expert in opioid crisis and treatment; serves on the Department of Homeland Security Science & Technology Directorate’s First Responder Resource Group and the EMS Support Team of the Department of Homeland Security/ Federal Emergency Management Agency.

Interview Questions
Q1.

Please tell us about your clinical experience. How many patients with opioid overdose do you see yearly? What is the most effective treatment for reversing the risk of death and disabilities associated with overdose?

Added By: c_admin
Q2.

Which are the most common purchased opioid reversal agents and why?

Added By: c_admin
Q3.

Have you used Opiant’s NARCAN - Nasal Spray in emergency situations, since its approval for opioid overdose?

Added By: c_admin
Q4.

The company cites nasal sprays have an advantage in more rapid absorption and higher plasma concentrations versus a nalmefene intramuscular injection. How much has standard of treatment changed because of this?

Added By: c_admin
Q5.

What’s been the response to the increase in opioid overdoses in the past years, with the introduction of synthetic opioids like fentanyl?

Added By: c_admin
Q6.

Opinant is testing OPNT003 with nasal naloxone in reversing the respiratory depression produced by the synthetic opioid, remifentanil. Could the potential efficacy also apply to other opioid drug overdoses?

Added By: c_admin
Q7.

How likely would you be to prescribe OPNT003 in the future, what’s its potential to become a new standard of care in the treatment of opioid overdose?

Added By: c_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.